FHIRsmith: AllergyIntolerance/AllergyIntolerance-allergyIntolerance-002.json

FHIR IG analytics

Package	ng.gov.nphcda.immunization
Resource Type	AllergyIntolerance
Id	AllergyIntolerance-allergyIntolerance-002.json
FHIR Version	R4

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: AllergyIntolerance allergyIntolerance-002

Profile: NG-Imm AllergyIntolerance

NG-Imm Allergy Dose Number: 457

NG-Imm Dose Series: Measles Infant Series

clinicalStatus: Resolved

verificationStatus: Confirmed

type: Allergy

category: Medication, Biologic

criticality: Low Risk

code: Measles morbillivirus and Rubella virus antigens only vaccine product

patient: Tolu Oluwatobi Adeyemi Male, DoB: 2022-09-21 ( MRN)

encounter: Encounter: extension = ; status = finished; class = PHC Center Level 2 (IMMZ.D.DE3 Facility Type CS#phc-center-l2)

onset: 2025-07-20 10:45:00+0100

recordedDate: 2025-07-20 11:30:00+0100

recorder: Practitioner Musa Abdullahi

lastOccurrence: 2025-07-21 08:00:00+0100

reaction
substance: Measles vaccine
manifestation: Fever, Maculopapular rash
description: Fever (38.5 °C) and rash developed within 24 hours after measles vaccine.
onset: 2025-07-20 18:00:00+0100
severity: Mild

Source1

{
  "resourceType": "AllergyIntolerance",
  "id": "allergyIntolerance-002",
  "meta": {
    "profile": [
      "https://nphcda.gov.ng/ig/StructureDefinition/allergy-intolerance-profile"
    ]
  },
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "https://nphcda.gov.ng/ig/StructureDefinition/allergy-reference-dose-number",
      "valueInteger": 457
    },
    {
      "url": "https://nphcda.gov.ng/ig/StructureDefinition/allergy-reference-dose-series",
      "valueString": "Measles Infant Series"
    }
  ],
  "clinicalStatus": {
    "coding": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical",
        "code": "resolved",
        "display": "Resolved"
      }
    ]
  },
  "verificationStatus": {
    "coding": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/allergyintolerance-verification",
        "code": "confirmed",
        "display": "Confirmed"
      }
    ]
  },
  "type": "allergy",
  "category": [
    "medication",
    "biologic"
  ],
  "criticality": "low",
  "code": {
    "coding": [
      {
        "system": "http://snomed.info/sct",
        "code": "871817003",
        "display": "Measles morbillivirus and Rubella virus antigens only vaccine product"
      }
    ]
  },
  "patient": {
    "reference": "Patient/patient-003"
  },
  "encounter": {
    "reference": "Encounter/encounter-002"
  },
  "onsetDateTime": "2025-07-20T10:45:00+01:00",
  "recordedDate": "2025-07-20T11:30:00+01:00",
  "recorder": {
    "reference": "Practitioner/practitioner-002"
  },
  "lastOccurrence": "2025-07-21T08:00:00+01:00",
  "reaction": [
    {
      "substance": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "871765008",
            "display": "Measles vaccine"
          }
        ]
      },
      "manifestation": [
        {
          "coding": [
            {
              "system": "http://snomed.info/sct",
              "code": "386661006",
              "display": "Fever"
            }
          ]
        },
        {
          "coding": [
            {
              "system": "http://snomed.info/sct",
              "code": "247471006",
              "display": "Maculopapular rash"
            }
          ]
        }
      ],
      "description": "Fever (38.5 °C) and rash developed within 24 hours after measles vaccine.",
      "onset": "2025-07-20T18:00:00+01:00",
      "severity": "mild"
    }
  ]
}